US 9513289
Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases
granted A61KA61K31/444A61K31/4709
Quick answer
US patent 9513289 (Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases) held by The United Sates of America, as Represented by the Department of Veterans Affairs expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United Sates of America, as Represented by the Department of Veterans Affairs
- Grant date
- Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/444, A61K31/4709, A61K38/00, A61P